We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,864
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Top Sells

Rank Stock Value
1
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$51.9M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$45.1M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$34.7M
4
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$27.3M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.81%
3 Healthcare 9.9%
4 Communication Services 9.49%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RUM icon
3401
RUM Group Inc
RUM
$3.7B
$23K ﹤0.01%
1,941
-1,922
-50% -$23.9K
SITC icon
3402
SITE Centers
SITC
$155M
$23K ﹤0.01%
1,775
-23,099
-93% -$281K
SPFI icon
3403
South Plains Financial
SPFI
$858M
$23K ﹤0.01%
879
+472
+116% +$13.4K
TNK icon
3404
Teekay Tankers
TNK
$2.95B
$23K ﹤0.01%
1,625
-1,265
-44% -$15.4K
TRDA icon
3405
Entrada Therapeutics
TRDA
$290M
$23K ﹤0.01%
2,485
+7
+0.3% +$75
UTMD icon
3406
Utah Medical Products
UTMD
$226M
$23K ﹤0.01%
254
-149
-37% -$13.7K
XBIT icon
3407
XBiotech
XBIT
$70.1M
$23K ﹤0.01%
2,625
+1,374
+110% +$13.8K
CMRX
3408
DELISTED
Chimerix, Inc.
CMRX
$23K ﹤0.01%
5,054
-23,913
-83% -$133K
VBFC
3409
DELISTED
Village Bank and Trust Financial Corp.
VBFC
$23K ﹤0.01%
+430
New +$24.5K
FBMS
3410
DELISTED
The First Bancshares, Inc.
FBMS
$23K ﹤0.01%
684
+260
+61% +$9.43K
ALTR
3411
DELISTED
Altair Engineering Inc
ALTR
$23K ﹤0.01%
361
-357
-50% -$22.5K
NBSE
3412
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$23K ﹤0.01%
604
-393
-39% -$13.6K
DWACU
3413
DELISTED
Digital World Acquisition Corp. Units
DWACU
$23K ﹤0.01%
301
+89
+42% +$7.7K
IMGN
3414
DELISTED
Immunogen Inc
IMGN
$23K ﹤0.01%
4,669
-19,735
-81% -$109K
PATI
3415
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
$23K ﹤0.01%
2,774
+223
+9% +$1.82K
IMPL
3416
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$23K ﹤0.01%
3,617
+188
+5% +$1.42K
SNRH
3417
DELISTED
Senior Connect Acquisition Corp. I Class A Common Stock
SNRH
$23K ﹤0.01%
2,276
+368
+19% +$3.6K
KBAL
3418
DELISTED
Kimball International
KBAL
$23K ﹤0.01%
2,756
+1,763
+178% +$16.7K
YELL
3419
DELISTED
Yellow Corporation Common Stock
YELL
$23K ﹤0.01%
3,282
-677
-17% -$6.46K
ACRS icon
3420
Aclaris Therapeutics
ACRS
$851M
$22K ﹤0.01%
1,300
-151
-10% -$2.06K
AMCX icon
3421
AMC Global Media
AMCX
$510M
$22K ﹤0.01%
542
-5,273
-91% -$213K
BFST icon
3422
Business First Bancshares
BFST
$1.05B
$22K ﹤0.01%
924
+383
+71% +$10.2K
CCBG icon
3423
Capital City Bank Group
CCBG
$898M
$22K ﹤0.01%
847
-2,329
-73% -$63.8K
CHCO icon
3424
City Holding Co
CHCO
$2.07B
$22K ﹤0.01%
281
+29
+12% +$2.33K
CORN icon
3425
Teucrium Corn Fund
CORN
$171M
$22K ﹤0.01%
+825
New +$19.8K
135 136
137
138 139

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,864 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.